Navigation Links
Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
Date:6/30/2009

ave sufficient financial resources to support the additional contemplated later-stage trials. Factors that could cause actual results to differ materially or otherwise adversely impact the company's ability to obtain regulatory approval for its product candidates include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical trials; obtaining additional financing to support our operations and the development of our products; obtaining regulatory approval for our technologies; anticipated timing of regulatory filings and the potential success in gaining regulatory approval and complying with governmental regulations applicable to our business. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended April 30, 2008 and the quarterly report on Form 10-Q for the quarter ended January 31, 2009. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Peregrine Pharmaceuticals, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

    Contacts:
    GendeLLindheim BioCom Partners
    Investors                                  Media
    info@peregrineinc.com                      Barbara Lindheim
    (800) 987-8256                             (212) 918-4650


'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 MMAR Medical is pleased to ... chance for regular customers to enjoy several perks and ... for a wholesale license. It’s a great choice for ... and others who regularly purchase medical braces but could ... your own active lifestyle or those of your club, ...
(Date:8/28/2014)... 28, 2014 On September 1st, the ... Back-to-School campaign. The goal is to help families ... calmly and effectively and without exposures to risky pesticides. ... agree: “Children’s exposures to pesticides should be limited ... , Head lice are often trivialized in the media, ...
(Date:8/27/2014)... Missouri (PRWEB) August 28, 2014 A ... Carey Danis & Lowe reports that the C.R. ... of thousands of consolidated transvaginal mesh lawsuits, recently filed ... PTO #136 pertains to the pretrial discovery process, and ... physically sensitive evidence. , Carey Danis & Lowe is ...
(Date:8/27/2014)... FL (PRWEB) August 27, 2014 ... money-saving dental plans, has launched in the state ... access to quality, affordable dental care services at ... destination for Tennessee consumers looking to save money ... dental rates as a member of discount fee ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 For ... and XML websites, ASP.NET hosting products are very ... ), Arvixe, and FatCow are the best ASP.NET ... has been known as a top web hosting ... for reliability remains with it today. Recently proclaimed ...
Breaking Medicine News(10 mins):Health News:MMAR Medical Announces Customer Membership Program 2Health News:Head Lice Can Be a Public Health Opportunity 2Health News:Head Lice Can Be a Public Health Opportunity 3Health News:Head Lice Can Be a Public Health Opportunity 4Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 2Health News:DentistSave.com Launches Discount Dental Plans in Tennessee for Consumers, Businesses, and Groups 3Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2
... and Medical Center, Phoenix, today announced the signing of ... for the deployment of the company,s state-of-the-art videoconferencing ... be used to connect specialist physicians at the hospital ... will include the Barrow Neurological Institute, as well as ...
... Essential survival gear for parents and guardians raising girls ... Changes (TM) is the leading product to help ... . (Photo: http://www.newscom.com/cgi-bin/prnh/20090512/LA13991 ) WHO: ... are Tara Harrington and Susanne Marcotte-Carroll, two ...
... percent lower in those who take supplements that long, research ... for at least a year before conception, folic acid supplements ... at least 50 percent, University of Texas researchers say. , ... PLoS Medicine , found no link to a reduction in ...
... who has developed a pioneering technique using microwaves to destroy ... UK and other patients are now being treated internationally. ... year die of primary liver cancer, with another million dying ... other tumour sites such as cancer of the colon. ...
... 2009) When Americans were asked to value the ... as they consider spending their own money, they chose ... revealed. , The Spectrum Health Value Study, the first ... representative sample of Americans over the past six months ...
... Human monoclonal antibodies effective against bird and seasonal ... colleagues, working with researchers at the Dana-Farber Cancer ... Prevention, reported the identification of human monoclonal antibodies ... viruses, including avian influenza A (H5N1) virus, previous ...
Cached Medicine News:Health News:St. Joseph's Hospital and Medical Center Signs Agreement for Innovative Video Conferencing Use 2Health News:Changes(TM) Kit for Girls - 'What Every Girl Wants.' 2Health News:Worldwide success in treatment of liver tumors 2Health News:Worldwide success in treatment of liver tumors 3Health News:Access to care leads Americans' priorities in first-ever public study of health value 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 2Health News:Recent developments at Burnham Institute for Medical Research, May 2009 3Health News:Recent developments at Burnham Institute for Medical Research, May 2009 4Health News:Recent developments at Burnham Institute for Medical Research, May 2009 5
(Date:8/27/2014)... , Aug. 27, 2014  Decision Resources ... specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and ... trials that a biosimilar has been assessed in ... product they choose to prescribe. ... report entitled Acceptance of Biosimilars Across ...
(Date:8/27/2014)... -- According to the new research ... Chairs, Dental Lasers), Current Trends, Opportunities - Global Forecast ... Market is expected to reach $7,138.9 million by ... a CAGR of 5.7% between 2014 and 2019. ... 61 figures spread through 167 pages and in-depth ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Heart Valve ... http://www.reportlinker.com/p02316644/Global-Heart-Valve-Repair-and-Replacement-Market-2014-2018.html About Heart Valve ... the human heart which control the flow of ... with heart valve diseases such as valvular stenosis, ...
Breaking Medicine Technology:Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... mm applier contains 20 titanium clips in the ... in the L size. The appliers are designed ... Auto Suture trocar sleeves, or larger sized trocar ... introduction of the ENDO CLIP clip applier through ...
... The Tissue Lock Clip is designed with ... superior on-vessel clip retention and improved hemostasis., ... design has a 20 percent greater angle ... placement., ,The Reflex® ELC has an ...
Insert only, Pilling-Weck small clip size...
Insert only, Ethicon, medium clip size...
Medicine Products: